Buscar
01/05/2026
Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation?
Bellofatto, IA, Nikolaou, PE, Andreadou, I, Canepa, M, Carbone, F, Ghigo, A, Heusch, G, Kleinbongard, P, Maack, C, Podesser, BK, Stamatelopoulos, K, Stellos, K, Vilahur, G, Montecucco, F, Liberale, L. Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation?. Clinical Research in Cardiology. 2026; 115(5)DOI:10.1007/s00392-024-02522-2. PMID:39167195. IF:3.700(Q1/3D).
01/05/2026
A five-year risk prediction model of cardiovascular disease in individuals with bipolar disorder: a nationwide register study from Sweden
Dobrosavljevic, M, Landén, M, Brikell, I, Chang, Z, Kuja-Halkola, R, Lichtenstein, P, Andell, P, Andreassen, OA, Bauer, M, Corcoy, R, De Girolamo, G, Reif, A, Larsson, H, Garcia-Argibay, M. A five-year risk prediction model of cardiovascular disease in individuals with bipolar disorder: a nationwide register study from Sweden. MOLECULAR PSYCHIATRY. 2026; 31(5)DOI:10.1038/s41380-025-03381-7. PMID:41420114. IF:10.100(Q1/1D).
01/05/2026
Lipid prevention in type 1 diabetes: From estimated risk to cumulative risk
Miñambres, I, Pérez, A. Lipid prevention in type 1 diabetes: From estimated risk to cumulative risk. Clinica E Investigacion En Arteriosclerosis. 2026; 38(3)DOI:10.1016/j.arteri.2026.500894. PMID:41690856. IF:(Q/D).
01/05/2026
Prevalence of germline variants in USP8, USP48, CABLES1 and PAM in patients with pituitary adenomas
de Lapiscina, IM, Baquero, C, Santos, A, Molina, AR, Moure, MD, Aramburu, M, Bancalari, R, Boronat, M, Bueno, G, Casano-Sancho, P, Fernandez-Ramos, C, Garcia-Garcia, E, Gonzalez, A, Gonzalez-Rivera, N, Guerrero-Fernandez, J, Hernandez, MI, Paja, M, Portillo, N, Rica, I, Soto-Moreno, A, Suarez-Ortega, L, Vela, A, Castaño, L, Valdes, N. Prevalence of germline variants in USP8, USP48, CABLES1 and PAM in patients with pituitary adenomas. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2026; 194(5)DOI:10.1093/ejendo/lvag074. PMID:42045809. IF:5.200(Q1/2D).